Market Tracker

12/19 6:05pm ET

Columbia Select Large Cap Growth ETF (RWG)

45.53
Data as of Dec 17
 0.00 / 0.00%
Today’s Change
39.70
Today|||52-Week Range
48.09
+5.44%
Year-to-Date

Investment Objective

The investment seeks long-term capital appreciation. The fund invests at least 80% of its net assets (including the amount of any borrowings for investment purposes) in equity securities of large capitalization companies that the investment manager believes have above-average growth prospects. It invests its net assets in common stocks of U.S. companies. These companies have market capitalizations in the range of companies in the Russell 1000  Growth Index (the index) at the time of purchase. The fund may invest in U.S. securities tied economically to foreign investments, such as American Depositary Receipts.

No recent news for Columbia Select Large Cap Growth ETF.

Performance

1 month+0.78% 3 years+22.78%
3 months+3.95% 5 years+14.71%
1 year+13.68% Since inception+15.50%
Data through 12/20/2014

Quote Details

Previous close$45.53
Open day’s range-- – --
Net asset value (NAV)47.86 (12/19/2014)
Daily volume0
Average volume (3 months)732
Data as of 12/17/2014

Peer Comparisonvs. Large growth ETFs

 RWGCategory
Performance 5-yr return+14.71%+17.36%
Expense Gross exp ratio2.56%0.44%
Risk 5 year sharpe ratio0.961.20
Net assets$12.1M$3.4B
Average market cap$36.4B$71.8B
Average P/E31.322.3
Dividend / Share--0.15%

Competitors

VOOG Vanguard S&P 500 Growth Index Fund ETF S...
IVW iShares S&P 500 Growth ETF
SPYG SPDR® S&P 500 Growth ETF

Holdings

Top 5 Sectors
Portfolio weighting
Financial service 27.21%
Healthcare 27.00%
Hardware 17.80%
Telecommunication 11.66%
Industrial materials 7.47%
Top 10 Holdings
Portfolio weighting
PCLN Priceline Group Inc5.10%
V Visa Inc Class A4.45%
CRM Salesforce.com Inc4.44%
VRTX Vertex Pharmaceuticals Inc4.35%
ILMN Illumina Inc4.26%
PCYC Pharmacyclics Inc4.21%
CELG Celgene Corp4.01%
BIIB Biogen Idec Inc3.85%
LNKD LinkedIn Corp Class A3.83%
BMY Bristol-Myers Squibb Company3.81%